Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

NCT ID: NCT02587221

Last Updated: 2020-06-17

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

6790 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2018-07-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aQIV

MF59-adjuvanted Quadrivalent Influenza Vaccine (aQIV)

Group Type EXPERIMENTAL

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)

Intervention Type BIOLOGICAL

1 dose approximately 0.5 mL of aQIV

Non-influenza Comparator Vaccine

Non-influenza comparator vaccine

Group Type PLACEBO_COMPARATOR

Non-Influenza Comparator (Boostrix)

Intervention Type BIOLOGICAL

1 dose approximately 0.5 mL dose of Non-influenza comparator vaccine (Boostrix)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)

1 dose approximately 0.5 mL of aQIV

Intervention Type BIOLOGICAL

Non-Influenza Comparator (Boostrix)

1 dose approximately 0.5 mL dose of Non-influenza comparator vaccine (Boostrix)

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females ≥ 65 years old who are healthy or have co-morbidities
2. Individuals who or whose legal guardian have voluntarily given written consent after the nature of the study has been explained according to local regulatory requirements, prior to study entry.
3. Ability to attend all scheduled visits and to comply with study procedures

Exclusion Criteria

1. Hypersensitivity, including allergy to any component of vaccines foreseen in this study
2. Abnormal function of the immune system.
3. Receipt of any influenza vaccine within 6 months prior to enrolment in this study or who plan to receive influenza vaccine while participating in the study.
4. Additional eligibility criteria may be discussed by contacting the site
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seqirus

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Program Manager

Role: STUDY_DIRECTOR

Seqirus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MHAT St. Ekaterina

Dimitrovgrad, , Bulgaria

Site Status

MHAT Sv Nikolay Chudotvoretz Lom

Lom, , Bulgaria

Site Status

MBAL TRIMONCIUM (Synexus)

Plovdiv, , Bulgaria

Site Status

SHATPPD-Ruse

Rousse, , Bulgaria

Site Status

Mhat Silistra

Silistra, , Bulgaria

Site Status

Mc Smolyan

Smolyan, , Bulgaria

Site Status

Mc Avicena Sofia

Sofia, , Bulgaria

Site Status

Medical Center Excelsior

Sofia, , Bulgaria

Site Status

Medical center Synexus Sofia EOOD

Sofia, , Bulgaria

Site Status

SHATPPD-Sofia, City

Sofia, , Bulgaria

Site Status

Medical Centre Orpheus OOD (Synexus)

Stara Zagora, , Bulgaria

Site Status

Hospital General de Medellín-Luz Castro de Gutiérrez - E.S.E

Medellín, Antioquia, Colombia

Site Status

Caja de Compesanción Familiar CAFAM

Bogotá, Cundinamarca, Colombia

Site Status

Fundacion Cardiomet CEQUIN - Internal Medicine

Armenia, , Colombia

Site Status

Clinica de la Costa

Barranquilla, , Colombia

Site Status

Centro de Atención e Investigación Médica S.A.S. - CAIMED S.A.S.

Bogotá, , Colombia

Site Status

Medplus Medicina Prepagada

Bogotá, , Colombia

Site Status

Asociacion IPS Medicos Internistas de Caldas

Manizales, , Colombia

Site Status

CCBR Czech Brno, s.r.o.

Brno, , Czechia

Site Status

Centrum ockovani a cestovni mediciny

Hradec Králové, , Czechia

Site Status

FN Hradec Kralove

Hradec Králové, , Czechia

Site Status

CCBR Ostrava, s.r.o.

Ostrava, , Czechia

Site Status

CCBR Czech, a.s.

Pardubice, , Czechia

Site Status

Center for Clinical and Basic Research

Tallinn, Harju, Estonia

Site Status

Medicum AS

Tallinn, Harju, Estonia

Site Status

Merelahe Family Doctors Centre

Tallinn, Harju, Estonia

Site Status

Vee Family Doctors Centre

Paide, Järvamaa, Estonia

Site Status

Clinical Research Center

Tartu, Tartu, Estonia

Site Status

Family Doctors Pullerits & Gavronski

Tartu, Tartu, Estonia

Site Status

Practice Dr Liga Kozlovska

Balvi, , Latvia

Site Status

Practice Dr Ruta Eglite

Kuldīga, , Latvia

Site Status

Family Doctor Andra Lasmane clinic "ALMA"

Riga, , Latvia

Site Status

Practice Dr Inese Petrova

Tukums, , Latvia

Site Status

JSC Saules seimos medicinos centras

Kaunas, , Lithuania

Site Status

Kauno klinikine ligonine

Kaunas, , Lithuania

Site Status

Lietuvos Sveikatos Mokslų Universitetas

Kaunas, , Lithuania

Site Status

UAB InMedica

Kaunas, , Lithuania

Site Status

Klaipeda University Hospital

Klaipėda, , Lithuania

Site Status

Republican Siauliai Hospital

Šiauliai, , Lithuania

Site Status

CCBR

Vilnius, , Lithuania

Site Status

Hospital Sultanah Bahiyah

Alor Star, , Malaysia

Site Status

Hospital Selayang

Batu Caves, , Malaysia

Site Status

Klinik Kesihatan Greentown

Ipoh, , Malaysia

Site Status

Hospital Raja Perempuan Zainab II

Kota Bharu, , Malaysia

Site Status

University Malaya Medical Centre (UMMC)

Kuala Lumpur, , Malaysia

Site Status

Klinik Kesihatan Seremban 2

Seremban, , Malaysia

Site Status

Hospital Seri Manjung

Seri Manjung, , Malaysia

Site Status

Hospital Sibu

Sibu, , Malaysia

Site Status

De La Salle Health Sciences Institute

Dasmariñas, Cavite, Philippines

Site Status

West Visayas State University - Medical Center

Jaro, Iloilo, Philippines

Site Status

Quirino Memorial Medical Center

Quezon City, National Capital Region, Philippines

Site Status

Marilao St. Michael Family Hospital

Bulacan, , Philippines

Site Status

Philippine General Hospital

Manila, , Philippines

Site Status

San Juan De Dios Hospital

Pasay, , Philippines

Site Status

Synexus Polska Sp. z o.o

Poznan, Greater Poland Voivodeship, Poland

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej VITAMED

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Synexus Polska Sp. z o.o.

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

NZOZ Centrum Medyczne "OMEGA" sp. z o.o.

Płock, Masovian Voivodeship, Poland

Site Status

Centrum Medyczne Pratia Warszawa

Warsaw, Masovian Voivodeship, Poland

Site Status

Specjalistyczny Osrodek Medycyny Wieku Dojrzalego

Warsaw, Masovian Voivodeship, Poland

Site Status

Synexus Polska Sp. z o.o.

Gdansk, Pomeranian Voivodeship, Poland

Site Status

Centrum Medyczne Pratia Gdynia

Gdynia, Pomeranian Voivodeship, Poland

Site Status

Centrum Medyczne Pratia Katowice

Katowice, Silesian Voivodeship, Poland

Site Status

Praktyka Lekarzy Rodzinnych SALUS

Katowice, Silesian Voivodeship, Poland

Site Status

Centrum Medyczne PRATIA Bydgoszcz

Bydgoszcz, , Poland

Site Status

Specjalistyczny Osrodek Medycyny Wieku Dojrzalego sp. z o.o.

Lodz, , Poland

Site Status

RCMed Oddział Nowy Duninow

Nowy Duninów, , Poland

Site Status

RCMed Oddzial Sochaczew

Sochaczew, , Poland

Site Status

Medical Trials Institute

Torun, , Poland

Site Status

Cabinet dr. Dana OLAR

Arad, , Romania

Site Status

Centrul Medical de Diagnostic si Tratament Ambulator NEOMED

Brasov, , Romania

Site Status

Cabinet Medical Individual Craciun-Nicodin Maria Marcela

Bucharest, , Romania

Site Status

Centrul Medical Sana

Bucharest, , Romania

Site Status

Clinica Medicala Synexus

Bucharest, , Romania

Site Status

Spitalul Clinic C.F. Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Clintrial Medical Center

Reșca, , Romania

Site Status

Fundatia Cardioprevent

Timișoara, , Romania

Site Status

Ramathibodi Hospital

Bangkok, , Thailand

Site Status

Mahidol University (MU) - Faculty of Tropical Medicine

Bangkok, , Thailand

Site Status

Khon Kaen University - Srinagarind Hospital - Medicine

Khon Kaen, , Thailand

Site Status

Bamrasnaradura Infectious Diseases Institute (BIDI)

Nonthaburi, , Thailand

Site Status

Ankara Training and Research Hospital

Ankara, , Turkey (Türkiye)

Site Status

Hacettepe University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Akdeniz University Medical Faculty

Antalya, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa Medical Faculty

Cerrahpaşa, , Turkey (Türkiye)

Site Status

Ataturk University Medical Faculty

Erzurum, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli University Research and Application Hospital

Kocaeli, , Turkey (Türkiye)

Site Status

Sakarya Training and Research Hospital

Sakarya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bulgaria Colombia Czechia Estonia Latvia Lithuania Malaysia Philippines Poland Romania Thailand Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Beran J, Reynales H, Poder A, Yu CY, Pitisuttithum P, Yuan LL, Vermeulen W, Verhoeven C, Leav B, Zhang B, Sawlwin D, Hamers-Heijnen E, Edelman J, Smolenov I. Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study. Lancet Infect Dis. 2021 Jul;21(7):1027-1037. doi: 10.1016/S1473-3099(20)30694-0. Epub 2021 Feb 9.

Reference Type DERIVED
PMID: 33577767 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-000728-27

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

V118_18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.